Hypocitraturia despite potassium citrate tablet supplementation

Area of Science:

• Nephrology
• Gastroenterology
• Biochemistry

Background:

• Recurrent nephrolithiasis with hypocitraturia is commonly managed with citrate supplementation.
• Potassium citrate is the standard oral citrate agent for this purpose.
• Chronic diarrheal syndromes can potentially impair gastrointestinal absorption.

Observation:

• A patient with recurrent kidney stones and chronic diarrhea presented with severe hypocitraturia.
• The patient was undergoing treatment with potassium citrate tablets.
• Despite supplementation, hypocitraturia persisted, suggesting impaired citrate absorption.

Findings:

• Slow-release wax-matrix potassium citrate tablets may lead to inadequate citrate absorption in patients with chronic diarrhea.
• This malabsorption can result in persistent hypocitraturia despite oral citrate therapy.
• Gastrointestinal absorption is a critical factor in the efficacy of oral citrate supplementation.

Implications:

• Alternative citrate formulations or administration routes may be necessary for patients with chronic diarrhea and hypocitraturia.
• Clinicians should consider potential malabsorption issues in patients with both chronic diarrhea and recurrent nephrolithiasis.
• Further research is warranted to optimize citrate delivery in patients with gastrointestinal motility disorders.